Author:
Sun Rongqi,Chen Tianli,Li Meng,Liu Zengli,Qiu Bo,Li Zhipeng,Xu Yunfei,Pan Chang,Zhang Zongli
Funder
Shandong Province Major Research and Design Program
Jinan City Science and Technology Development Program
Hengrui Hepatobiliary and Pancreatic Foundation
Subject
Pharmacology,General Medicine
Reference31 articles.
1. Cholangiocarcinoma;Squadroni;Crit. Rev. Oncol. Hematol.,2017
2. Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling;Xu;J. Cell. Mol. Med.,2018
3. Cholangiocarcinoma;Razumilava;Lancet,2014
4. Cholangiocarcinoma - evolving concepts and therapeutic strategies, Nature reviews;Rizvi;Clin. Oncol.,2018
5. Cholangiocarcinoma: current knowledge and new developments;Blechacz;Gut Liver,2017
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献